Fragment-Based Drug Discovery Applied to Hsp90. Discovery of Two Lead Series with High Ligand Efficiency
Author:
Affiliation:
1. Astex Therapeutics, Ltd., 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, U.K.
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/jm100059d
Reference85 articles.
1. Molecular Chaperones and Protein Quality Control
2. Drugging the Cancer Chaperone HSP90: Combinatorial Therapeutic Exploitation of Oncogene Addiction and Tumor Stress
3. HSP90 and the chaperoning of cancer
4. The Hallmarks of Cancer
5. Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone
Cited by 166 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. From Static to Dynamic Structures: Improving Binding Affinity Prediction with Graph‐Based Deep Learning;Advanced Science;2024-08-29
2. Automated Absolute Binding Free Energy Calculation Workflow for Drug Discovery;Journal of Chemical Information and Modeling;2024-07-02
3. Synthesis of 3-hydroxybenzoic acid derivatives via photochemical rearrangement of 6-substituted bicyclo[3.1.0]hex-3-en-2-ones;Canadian Journal of Chemistry;2024-06-04
4. Target-based drug design strategies to overcome resistance to antiviral agents: opportunities and challenges;Drug Resistance Updates;2024-03
5. Combined In-Solution Fragment Screening and Crystallographic Binding-Mode Analysis with a Two-Domain Hsp70 Construct;ACS Chemical Biology;2024-02-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3